Close Menu

newborn screening

NEW YORK (GenomeWeb News) – The committee that advises the US Department of Health and Human Services on matters related to newborn screening for genetic diseases, and sets the newborn screening standards followed by many states, is set to expire in April and advocates are pressing to get it reau

NEW YORK (GenomeWeb News) – Blood samples that are left over from newborn screening tests offer a treasure trove of research materials for scientists seeking to uncover the role of genes in diseases and health, and the science community should be pushing for policies that promote their use in res

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development are preparing a new grant program that will provide $25 million to fund studies that look at how genome sequencing may be used in newbor

Asuragen has been awarded a one-year, $346,000 grant from the National Institute of Child Health and Human Development to develop a high-throughput version of its PCR-based fragile X syndrome test for use in newborn population screening, according to a recently published grant ab

Blood spots may be a benefit to public health research, but the mandatory collection process may be stoking public concerns about government and privacy, one pediatrician argues.

The researchers — who previously demonstrated that PCR-based CMV testing of commonly collected dried blood spots had low sensitivity compared to rapid culture — have made a strong case for saliva-based testing as a more promising tool to screen newborns for CMV, a leading cause of hearing loss in children.

Luminex will be going after a piece of the newborn screening market, estimated to be a $100 million-plus opportunity, with a new assay slated for an initial launch in Europe later this year.

Two sets of grants will support genome-based research into diseases for which newborns are screened.

It remains to be seen whether a market for PCR-based fragile X population screening will soon develop, since mandating newborn testing may be highly dependent on the development of a difference-making therapeutic; and carrier screening will likely continue to rely on a case-by-case cost-benefit analysis.

Pages

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.